Evidence map›Paper›PMID 25712404›Full record

ArticleAngewandte Chemie (International ed. in English)2015

Discovery and reconstitution of the cycloclavine biosynthetic pathway--enzymatic formation of a cyclopropyl group.

Dorota Jakubczyk, Lorenzo Caputi, Anaëlle Hatsch, Curt A F Nielsen, Melanie Diefenbacher, Jens Klein, Andrea Molt, Hartwig Schröder, Johnathan Z Cheng, Michael Naesby and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
21.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 73 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. A hybrid system for the overproduction of complex ergot alkaloid chanoclavine.Frontiers in bioengineering and biotechnology · 2022
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Ergot Alkaloid Synthesis Capacity of Penicillium camemberti.Applied and environmental microbiology · 2018
    Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Dorota JakubczykDepartment of Biological Chemistry, John Innes Centre, Colney Lane, Norwich (UK).
Lorenzo Caputi
Anaëlle Hatsch
Curt A F Nielsen
Melanie Diefenbacher
Jens Klein
Andrea Molt
Hartwig Schröder
Johnathan Z Cheng
Michael Naesby
Sarah E O'Connor
John Innes Centre · GBEvolva (Switzerland) · CHBASF (Germany) · DE

Funding

Biotechnology and Biological Sciences Research Council BB/J018171/1
6 · The paper itself

Abstract

The ergot alkaloids, a class of fungal-derived natural products with important biological activities, are derived from a common intermediate, chanoclavine-I, which is elaborated into a set of diverse structures. Herein we report the discovery of the biosynthetic pathway of cycloclavine, a complex ergot alkaloid containing a cyclopropyl moiety. We used a yeast-based expression platform along with in vitro biochemical experiments to identify the enzyme that catalyzes a rearrangement of the chanoclavine-I intermediate to form a cyclopropyl moiety. The resulting compound, cycloclavine, was produced in yeast at titers of >500 mg L(-1) , thus demonstrating the feasibility of the heterologous expression of these complex alkaloids.

Indexed as

Aspergillus fumigatusCyclopropanesEnzymesErgot AlkaloidsFungal ProteinsIndole AlkaloidsMultigene FamilySaccharomyces cerevisiaecycloclavinecyclopropaneCyclopropanesEnzymesErgot AlkaloidsFungal ProteinsIndole Alkaloidsbiosynthesiscyclopropyl groupergot alkaloidsnatural productspathway reconstitution

Identifiers

PMID25712404
PMCPMC4471609
OpenAlexW2116337631

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.